Prostate Cancer - Results from #26160

A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index - Abstract March 23, 2012

Denosumab: First data and ongoing studies on the prevention of bone metastases - Abstract March 23, 2012

Bisphosphonates: Prevention of bone metastases in prostate cancer - Abstract March 23, 2012

Impact of a prostate multidisciplinary clinic program on patient treatment decisions and on adherence to NCCN guidelines: The William Beaumont Hospital Experience - Abstract March 23, 2012

Transperineal template-guided mapping biopsy as a staging procedure to select patients best suited for active surveillance - Abstract March 23, 2012

An overview of prostate diseases and their characteristics specific to Asian men - Abstract March 23, 2012

Rationing in urologic oncology: Lessons from sipuleucel-T for advanced prostate cancer - Abstract March 22, 2012

Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies - Abstract March 22, 2012

Biopsy and implantation of the seminal vesicles - Abstract March 22, 2012

The efficacy of exercise in reducing depressive symptoms among cancer survivors: A meta-analysis - Abstract March 22, 2012

Functional outcomes in African-Americans following robotic-assisted radical prostatectomy (RARP) - Abstract March 22, 2012

Simulation optimization of PSA-threshold based prostate cancer screening policies - Abstract March 22, 2012

Changes in biomarkers of inflammation and angiogenesis during androgen deprivation therapy for prostate cancer - Abstract March 22, 2012

Prostate cancer risk prediction in a urology clinic in Mexico - Abstract March 22, 2012

Do additional cores from MRI cancer-suspicious lesions to systematic 12-core transrectal prostate biopsy give better cancer detection? - Abstract March 21, 2012

Circulating tumour cells in prostate cancer patients receiving salvage radiotherapy - Abstract March 21, 2012

Detailed biopsy pathologic features as predictive factors for initial reclassification in prostate cancer patients eligible for active surveillance - Abstract March 21, 2012

Urinary morbidity after permanent prostate brachytherapy - Impact of dose to the urethra vs. sources placed in close vicinity to the urethra - Abstract March 21, 2012

The number of high-risk factors and the risk of prostate cancer-specific mortality after brachytherapy: Implications for treatment selection - Abstract March 21, 2012

Predicting rectal and bladder overdose during the course of prostate radiotherapy using dose-volume data from initial treatment fractions - Abstract March 21, 2012

Page 1309 of 1436